Department of Radiology, Yokohama City University Graduate School of Medicine, Yokohama, Kanagawa, 236-0004 Japan.
Anticancer Res. 2012 Aug;32(8):3315-20.
Extramammary Paget's disease (EMPD) is frequently inoperable because of old age and/or coexisting disease. We therefore reviewed the efficacy and toxicity of radiation therapy for EMPD.
Fourteen patients with EMPD underwent definitive radiation therapy. Three patients had regional lymph node metastases before radiation therapy, but none had distant metastasis. Total doses of 52-80.2 Gy (median=60.6 Gy) were delivered to tumor sites in 26-43 fractions (median=33 fractions).
Four patients had developed recurrence at a median follow-up period of 47 months. The 5-year local control and disease-free rates were 71% and 63%, respectively. Two patients died of old age and renal failure at 6 and 51 months, respectively, after irradiation. The 5-year disease-free, cause-specific and overall survival rates were 46%, 100% and 79%, respectively. No therapy-related toxicities of grade 3 or greater were observed.
Radiation therapy is effective and safe, and appears to offer a curative treatment option for patients with EMPD.
由于年龄和/或并存疾病,外分泌性帕哲病(EMPD)常无法手术。因此,我们回顾了 EMPD 的放射治疗效果和毒性。
14 名 EMPD 患者接受了根治性放射治疗。3 名患者在放射治疗前有区域性淋巴结转移,但无远处转移。肿瘤部位的总剂量为 52-80.2Gy(中位数=60.6Gy),共 26-43 次(中位数=33 次)。
4 例患者在中位随访 47 个月时复发。5 年局部控制率和无病生存率分别为 71%和 63%。2 例患者分别在放疗后 6 个月和 51 个月因高龄和肾衰竭死亡。5 年无病生存率、特异性生存率和总生存率分别为 46%、100%和 79%。未观察到 3 级或更高级别的治疗相关毒性。
放射治疗有效且安全,似乎为 EMPD 患者提供了一种治愈性的治疗选择。